Clinical Trial Update: Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating bevacizumab and paclitaxel for neuroendocrine tumors of the cervix; the study was terminated and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Uterine Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Cancer, Uterine Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-07